Association of Metabolic Syndrome Components and Nutritional Status with Kidney Cancer in Young Adult Population: A Nationwide Population-Based Cohort Study in Korea

Overview

Journal Biomedicines

Specialty Biomedical Engineering

Date 2023 May 27

PMID 37239096

Authors

Hee Yeon Lee

Kyung-Do Han

In Sook Woo

Hyuk-Sang Kwon

Affiliations

Soon will be listed here.

Abstract

The aim of this study was to determine the association of metabolic syndrome (MetS) with kidney cancer and the impact of age and gender on such an association. Using the Korean National Health Insurance Service database, 9,932,670 subjects who had check-ups in 2009 were followed up until the diagnosis of kidney cancer or death or until 2019. Kidney cancer was significantly associated with MetS (HR 1.56). This association was higher in the younger age group (HR: 1.82, 1.5, and 1.37 in 20-39 years, 40-64 years, and ≥65 years, respectively). In terms of the association of kidney cancer with obesity and central obesity, young-aged males showed higher HR for kidney cancer than old-aged ones (HR of obesity: 1.96, 1.52, and 1.25; HR of central obesity: 1.94, 1.53, and 1.3 in 20-39 years, 40-64 years, ≥65 years, respectively), while young-aged females showed lower HR. Kidney cancer was associated with obesity and MetS. The association was higher in younger populations than in older ones. Regarding gender, MetS, obesity, and central obesity showed higher associations with kidney cancer in younger aged male population, while there was no significant difference in such associations according to age in the female population.

Citing Articles

Metabolic syndrome and increased susceptibility to renal cell carcinoma - a meta-analysis.

Zhou Y, Chen Y, Yang H, Xu Z, Zhuang J, Bian Q BMC Nephrol. 2025; 26(1):102.

PMID: 40012054 PMC: 11863896. DOI: 10.1186/s12882-025-04013-6.

Cumulative Burden of Fatty Liver and Kidney Cancer in Young Men: A National Population-Based Study.

Lee H, Han K, Kwon H J Clin Med. 2025; 14(1.

PMID: 39797231 PMC: 11721000. DOI: 10.3390/jcm14010148.

Global obesity epidemic and rising incidence of early-onset cancers.

Chen J, Dalerba P, Terry M, Yang W J Glob Health. 2024; 14:04205.

PMID: 39391900 PMC: 11467775. DOI: 10.7189/jogh.14.04205.

Association between metabolic syndrome and kidney cancer risk: a prospective cohort study.

Wang L, Du H, Sheng C, Dai H, Chen K Lipids Health Dis. 2024; 23(1):142.

PMID: 38760801 PMC: 11100063. DOI: 10.1186/s12944-024-02138-5.

References

Ko S, Han K, Yun J, Chung S, Koh E . Impact of obesity and diabetes on the incidence of kidney and bladder cancers: a nationwide cohort study. Eur J Endocrinol. 2019; 181(5):489-498. DOI: 10.1530/EJE-19-0500. View

Adams K, Leitzmann M, Albanes D, Kipnis V, Moore S, Schatzkin A . Body size and renal cell cancer incidence in a large US cohort study. Am J Epidemiol. 2008; 168(3):268-77. PMC: 2727262. DOI: 10.1093/aje/kwn122. View

Alberti K, Eckel R, Grundy S, Zimmet P, Cleeman J, Donato K . Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation;.... Circulation. 2009; 120(16):1640-5. DOI: 10.1161/CIRCULATIONAHA.109.192644. View

Safiri S, Kolahi A, Mansournia M, Almasi-Hashiani A, Ashrafi-Asgarabad A, Sullman M . The burden of kidney cancer and its attributable risk factors in 195 countries and territories, 1990-2017. Sci Rep. 2020; 10(1):13862. PMC: 7431911. DOI: 10.1038/s41598-020-70840-2. View

Tseng C . Type 2 Diabetes Mellitus and Kidney Cancer Risk: A Retrospective Cohort Analysis of the National Health Insurance. PLoS One. 2015; 10(11):e0142480. PMC: 4641625. DOI: 10.1371/journal.pone.0142480. View

Neovius M, Sundstrom J, Rasmussen F . Combined effects of overweight and smoking in late adolescence on subsequent mortality: nationwide cohort study. BMJ. 2009; 338:b496. PMC: 2651106. DOI: 10.1136/bmj.b496. View

Sin S, Lee C, Choi S, Han K, Lee J . Metabolic Syndrome and Risk of Lung Cancer: An Analysis of Korean National Health Insurance Corporation Database. J Clin Endocrinol Metab. 2020; 105(11). DOI: 10.1210/clinem/dgaa596. View

Song W, He D, Chen Y, Yeh C, Hsu I, Huang Q . Targeting newly identified ERβ/TGF-β1/SMAD3 signals with the FDA-approved anti-estrogen Faslodex or an ERβ selective antagonist in renal cell carcinoma. Mol Oncol. 2018; 12(12):2055-2071. PMC: 6275262. DOI: 10.1002/1878-0261.12377. View

Czarnecka A, Niedzwiedzka M, Porta C, Szczylik C . Hormone signaling pathways as treatment targets in renal cell cancer (Review). Int J Oncol. 2016; 48(6):2221-35. DOI: 10.3892/ijo.2016.3460. View

10.

Yu C, Ho J, Huang Y, Cha T, Sun G, Yu D . Estrogen inhibits renal cell carcinoma cell progression through estrogen receptor-β activation. PLoS One. 2013; 8(2):e56667. PMC: 3584057. DOI: 10.1371/journal.pone.0056667. View

11.

Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424. DOI: 10.3322/caac.21492. View

12.

Bao C, Yang X, Xu W, Luo H, Xu Z, Su C . Diabetes mellitus and incidence and mortality of kidney cancer: a meta-analysis. J Diabetes Complications. 2013; 27(4):357-64. DOI: 10.1016/j.jdiacomp.2013.01.004. View

13.

Oh T, Han K, Choi H, Kim C, Bae E, Ma S . Metabolic Syndrome Resolved within Two Years is Still a Risk Factor for Kidney Cancer. J Clin Med. 2019; 8(9). PMC: 6780562. DOI: 10.3390/jcm8091329. View

14.

Hidayat K, Du X, Zou S, Shi B . Blood pressure and kidney cancer risk: meta-analysis of prospective studies. J Hypertens. 2017; 35(7):1333-1344. DOI: 10.1097/HJH.0000000000001286. View

15.

Lee Y, Han K, Ko S, Ko K, Lee K . Data Analytic Process of a Nationwide Population-Based Study Using National Health Information Database Established by National Health Insurance Service. Diabetes Metab J. 2016; 40(1):79-82. PMC: 4768054. DOI: 10.4093/dmj.2016.40.1.79. View

16.

di Meo N, Lasorsa F, Rutigliano M, Loizzo D, Ferro M, Stella A . Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets. Int J Mol Sci. 2022; 23(22). PMC: 9698586. DOI: 10.3390/ijms232214360. View

17.

Kim S, Han K, Joo Y . Metabolic Syndrome and Incidence of Laryngeal Cancer: A Nationwide Cohort Study. Sci Rep. 2019; 9(1):667. PMC: 6345961. DOI: 10.1038/s41598-018-37061-0. View

18.

Shen T, Shu X, Xiang Y, Li H, Cai H, Gao Y . Association of hypertension and obesity with renal cell carcinoma risk: a report from the Shanghai Men's and Women's Health Studies. Cancer Causes Control. 2015; 26(8):1173-80. PMC: 4500104. DOI: 10.1007/s10552-015-0611-7. View

19.

Scelo G, Larose T . Epidemiology and Risk Factors for Kidney Cancer. J Clin Oncol. 2018; :JCO2018791905. PMC: 6299342. DOI: 10.1200/JCO.2018.79.1905. View

20.

Park J, Choi I, Han K, Park H, Kim K, Kim J . Association Between Fatty Liver Index and Risk of Breast Cancer: A Nationwide Population-Based Study. Clin Breast Cancer. 2020; 20(4):e450-e457. DOI: 10.1016/j.clbc.2020.02.004. View